Earlier Alzheimer's Diagnosis May Be Possible With New Imaging Compound

News Researchers have developed a chemical compound, named Fluselenamyl, that detects amyloid clumps better than current FDA-approved compounds. Contributed Author: Washington University School of Medicine Topics: Neurology